AzTrials
AzTrials

Anterior Cruciate Ligament InjuryACL SNNAPNCT02980367

ACL SNNAP Trial: ACL Surgery Necessity in Non Acute Patients

A study testing Non-Surgical Management (Rehabilitation) and Surgical Management (Reconstruction) in people with Anterior Cruciate Ligament Injury, run by University of Oxford at 32 sites in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary objective of this study is to determine in patients with non-acute Anterior Cruciate Ligament Deficiency (ACLD) whether a strategy of non-surgical management [Rehabilitation] (with option for later ACL reconstruction, only if required) is more clinically effective and cost effective than a strategy of… Read more about this study

Who is it for?
Ages 18 to 99 years
Conditions the study is for
Anterior Cruciate Ligament Injury
What is being tested?
Non-Surgical Management (Rehabilitation) and Surgical Management (Reconstruction)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
320 participants
Where
32 sitesUnited Kingdom
Study dates
Dec 2016to Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 years or above.
  • Symptomatic ACL deficiency of the native ligament1 (instability-episodes of frank giving way or feeling unstable) with ACL deficiency (either partial or complete tear) confirmed using clinical assessment and MRI scan.

Who cannot join

  • Acute phase of primary ACL injury i.e. not recovered from any acute symptoms relating to their initial ACL injury.
  • Previous knee surgery (other than diagnostic arthroscopy or partial meniscectomy) to index knee concomitant severe injury to contra-lateral knee.
  • Meniscal pathology with characteristics that indicate immediate surgery i.e. locked knee, large bucket handle or complex cartilage tear producing mechanical symptoms.
  • Knee joint status of grade 3 or 4 on the Kellgren and Lawrence scale,
  • Grade 3 MCL/LCL injury, associated PCL/PLC injury
  • Inflammatory arthropathy.
  • Pregnancy.

Trial locations and contacts

32 sites in 1 country.

32 sites in 1 country

United Kingdom32 sites, 32 recruiting
  • Betsi Cadwaladr University Health Board

    Bangor

    Recruiting
  • Basildon and Thurrock University Hospitals NHS Foundation Trust

    Basildon

    Sean Symons

    Recruiting
  • North Bristol NHS Trust

    Bristol

    James Murray

    Recruiting
  • Gloucestershire Hospitals NHS Foundation Trust

    Cheltenham

    Recruiting
  • Countess of Chester Hospital NHS Foundation Trust

    Chester

    Raghuram Thonse

    Recruiting
  • University Hospitals Coventry and Warwickshire NHS Trust

    Coventry

    Recruiting
  • Frimley Health NHS Foundation Trust

    Frimley

    Recruiting
  • Royal Surrey County Hospitals NHS Foundation Trust

    Guildford

    Oliver Templeton-Ward

    Recruiting
  • Hull and East Yorkshire Hospitals NHS Trust

    Hull

    Reza Mayahi

    Recruiting
  • Leeds Teaching Hospitals NHS Trust

    Leeds

    Recruiting
  • University Hospitals of Leicester

    Leicester

    Recruiting
  • Kings College Hospital NHS Foundation Trust

    London

    Barry Andrews

    Recruiting
  • University College London Hospitals NHS Foundation Trust

    London

    Recruiting
  • Manchester University NHS Foundation Trust

    Manchester

    Pankaj Sharma

    Recruiting
  • Oxford University Hospitals NHS Foundation Trust

    Oxford

    Recruiting
  • North West Anglia NHS Foundation Trust

    Peterborough

    Recruiting
  • Portsmouth Hospitals NHS Trust

    Portsmouth

    Jeremy Rushbrook

    Recruiting
  • Royal Berkshire NHS Foundation Trust

    Reading

    Recruiting
  • Salisbury NHS Foundation Trust

    Salisbury

    Leonidas Vachtsevanos

    Recruiting
  • Sheffield Teaching Hospitals NHS Foundation Trust

    Sheffield

    Recruiting
  • Frimley Health NHS Foundation Trust

    Slough

    Recruiting
  • Stockport NHS Foundation Trust

    Stockport

    David Johnson

    Recruiting
  • Sherwood Forest Hospitals NHS Foundation Trust

    Sutton in Ashfield

    Recruiting
  • Abertawe Bro Morannwg University Health Board

    Swansea

    Recruiting
  • Great Western Hospitals NHS Foundation Trust

    Swindon

    Recruiting
  • Taunton and Somerset NHS Foundation Trust

    Taunton

    Andrew Kelly

    Recruiting
  • Royal Cornwall Hospitals NHS Trust

    Truro

    Robin Kincaid

    Recruiting
  • The Mid Yorkshire Hospitals NHS Trust

    Wakefield

    Jon Smith

    Recruiting
  • Warrington and Halton Hospitals NHS Foundation Trust

    Warrington

    Recruiting
  • Wrightington, Wigan and Leigh NHS Foundation Trust

    Wigan

    Ben Coupe

    Recruiting
  • Betsi Cadwaladr University Health Board

    Wrexham

    Yeogesh Joshi

    Recruiting
  • Yeovil District Hospital NHS Foundation Trust

    Yeovil

    Recruiting

Other trials in United Kingdom

About this study

Official title: Comparison of the Clinical and Cost Effectiveness of Two Management Strategies for Non-acute Anterior Cruciate Ligament (ACL) Injury: Rehabilitation Versus Surgical Reconstruction.

The primary objective of this study is to determine in patients with non-acute Anterior Cruciate Ligament Deficiency (ACLD) whether a strategy of non-surgical management [Rehabilitation] (with option for later ACL reconstruction, only if required) is more clinically effective and cost effective than a strategy of surgical management [Reconstruction].

Read the detailed description

The ACL SNNAP study is a pragmatic multi-centre randomised controlled trial with two-arm parallel groups and 1:1 allocation ratio to compare non-surgical management (Rehabilitation) and surgical management (Reconstruction) options for patients with a symptomatic non-acute ACL deficient knee.

The objective is to determine, in patients with non-acute Anterior Cruciate Ligament Deficiency (ACLD), whether non-surgical treatment (with the option for later ACL reconstruction if required) is more effective than surgical ACL reconstruction (as measured by the Knee Injury and Osteoarthritis Outcome Score [KOOS4] at 18 months from randomisation).

Target sample size is 320 patients recruited from approx. 30 NHS orthopaedic units.

An internal pilot will be conducted with clear progression criteria regarding recruitment.

Both interventions are routine NHS treatments. Intervention content is based on a minimal set of pre-established criteria in order to ensure the integrity of the comparison while allowing for varying in practice in delivering the interventions between both surgeons and physiotherapists. This largely pragmatic approach will allow clinical management to reflect current practice and resource use within the NHS thus aiding generalisation.

Other than the allocated intervention, both groups will be followed-up in the same way to exclude bias. Follow up for study purposes will be by patient self-reported questionnaire completed using an electronic data capture collection system (a postal option will also be available). The questionnaire will include the outcomes indicated in section 4 and will be completed by participants at baseline, 6, 12 and 18 months. Non-response will be minimised through use of multiple reminders such as web based, phone and text.

Neither participants nor health care practitioners (surgeons and physiotherapists) can be blinded to receipt of the intervention.

Being tested
Non-Surgical Management (Rehabilitation), Surgical Management (Reconstruction)
Keywords
Anterior Cruciate Ligament, ACL, Anterior Cruciate Ligament deficiency, ACL deficiency, ACLD, Anterior Cruciate Ligament reconstruction, ACL reconstruction, Anterior Cruciate Ligament physiotherapy, Anterior Cruciate Ligament rehabilitation, ACL physiotherapy, ACL rehabilitation, Anterior Cruciate Ligament management, ACL management
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-Surgical Management (Rehabilitation)Other

    Also called Physical Therapy, Physiotherapy, Conservative Rehabilitation, Conservative Management

    Routine ACL rehabilitation protocols used at the participating site will be followed. As part of the site selection process, documentary evidence of the use of or willingness to adopt a rehabilitation protocol that reflects the guidelines of the mandatory aims/goals set for the study rehabilitation intervention will be required.

  • Surgical Management (Reconstruction)Procedure or surgery

    Also called ACL Reconstruction, ACLR, ACL surgery, Anterior Cruciate Ligament Surgery

    All surgical reconstructions will be patella tendon or hamstrings tendon depending on the surgeon's preference. All other care will be routine, including immediate post-operative care.

Study groups in NCT02980367
Study groupRoleWhat they receive
ACL Rehabilitation GroupExperimentalNon-surgical management [Rehabilitation] with option for later Anterior Cruciate Ligament (ACL) reconstruction, only if required.
Receives: Other: Non-Surgical Management (Rehabilitation)
ACL Reconstruction GroupActive comparatorSurgical Management - Anterior Cruciate Ligament (ACL) reconstruction surgery
Receives: Procedure: Surgical Management (Reconstruction)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knee Injury and Osteoarthritis Outcome Score (KOOS4)

    The score is derived from 4 of 5 subscales; pain, symptoms, difficulty in sports and recreational activities, knee related quality of life.

    Measured: 18 months post randomisation

Secondary outcomes (7)
  1. Knee Injury and Osteoarthritis Outcome Score (KOOS)

    All 5 subscales of the KOOS will be included (the fifth scale being activities of daily living).

    Anterior Cruciate Ligament Quality of Life Score (ACL-QOL)

    Measured: At baseline and at 6, 12 and 18 months post randomisation

  2. Modified Tegner scale

    Activity level will be assessed using the Modified Tegner scale, graded from 1 (low activity levels) to 10 (professional level).

    Measured: At baseline and at 6, 12 and 18 months post randomisation

  3. Intervention related complications

    Any complications associated with undergoing ACL deficiency treatment will be recorded. This includes; for surgery group; re-admission, delayed hospital discharge, infection, unexpected poor range of movement (stiffness), excess bleeding, continued swelling, episodes of giving way, continued feeling of instability. For non-surgical group; continued swelling, episodes of giving way.

    Measured: At 6, 12 and 18 months post randomisation

  4. EuroQol EQ-5D-5L

    Generic quality of life (self-reported outcome measure covering 5 health domains and used to facilitate the calculation of Quality Adjusted Life Years in health economic evaluations).

    Measured: At baseline and at 6, 12 and 18 months post randomisation

  5. Resource-usage data

    Detailed resource use data on initial treatments received (surgical reconstruction or rehabilitation) and on subsequent healthcare contacts including re-operations (surgery arm), subsequent surgical reconstructions (rehabilitation arm), surgery-related complications, further rehabilitation, and primary care and other secondary care contacts out to 18 months post-randomisation. In addition, data will be collected on ability to work (e.g. sickness absences/return to work number of days off work and subjective working ability).

    Measured: 18 months post randomisation

  6. Anterior Cruciate Ligament Quality of Life score (ACL-QOL)

    Expectations of return to activity and confidence in relation to the knee.

    Measured: At baseline and at 6, 12 and 18 months post randomisation

  7. Patient satisfaction

    Simple Likert scale

    Measured: At baseline and at 6, 12 and 18 months post randomisation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2016 (estimated)
  2. Study startDec 2016
  3. Primary completionNov 2021 (estimated)
  4. Study completionMar 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
320 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02980367
Sponsor's protocol ID
12096
Acronym
ACL SNNAP
Status last verified
Nov 2020
First submitted
17 Nov 2016
Last updated
15 Oct 2021
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Undecided

Publications

  • Beard DJ, Davies L, Cook JA, Stokes J, Leal J, Fletcher H, Abram S, Chegwin K, Greshon A, Jackson W, Bottomley N, Dodd M, Bourke H, Shirkey BA, Paez A, Lamb SE, Barker KL, Phillips M, Brown M, Lythe V, Mirza B, Carr A, Monk P, Areia CM, O'Leary S, Haddad F, Wilson C, Price A; ACL SNNAP Study Group. Comparison of surgical or non-surgical management for non-acute anterior cruciate ligament injury: the ACL SNNAP RCT. Health Technol Assess. 2024 Jun;28(27):1-97. doi: 10.3310/VDKB6009.

    PubMed 38940695
  • Beard DJ, Davies L, Cook JA, Stokes J, Leal J, Fletcher H, Abram S, Chegwin K, Greshon A, Jackson W, Bottomley N, Dodd M, Bourke H, Shirkey BA, Paez A, Lamb SE, Barker K, Phillips M, Brown M, Lythe V, Mirza B, Carr A, Monk P, Morgado Areia C, O'Leary S, Haddad F, Wilson C, Price A; ACL SNNAP Study Group. Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trial. Lancet. 2022 Aug 20;400(10352):605-615. doi: 10.1016/S0140-6736(22)01424-6.

    PubMed 35988569
  • Davies L, Cook J, Leal J, Areia CM, Shirkey B, Jackson W, Campbell H, Fletcher H, Carr A, Barker K, Lamb SE, Monk P, O'Leary S, Haddad F, Wilson C, Price A, Beard D. Comparison of the clinical and cost effectiveness of two management strategies (rehabilitation versus surgical reconstruction) for non-acute anterior cruciate ligament (ACL) injury: study protocol for the ACL SNNAP randomised controlled trial. Trials. 2020 May 14;21(1):405. doi: 10.1186/s13063-020-04298-y.

    PubMed 32410697

Questions about this trial

What is this clinical trial studying?

A study testing Non-Surgical Management (Rehabilitation) and Surgical Management (Reconstruction) in people with Anterior Cruciate Ligament Injury, run by University of Oxford at 32 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 32 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact David Beard (01865 737210, ACL_SNNAP@ndorms.ox.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knee Injury and Osteoarthritis Outcome Score (KOOS4) (time frame: 18 months post randomisation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02980367, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in